190 related articles for article (PubMed ID: 33085641)
1. The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma.
Piber P; Vavpetic N; Goricar K; Dolzan V; Kovac V; Franko A
Radiol Oncol; 2020 Oct; 54(4):429-436. PubMed ID: 33085641
[TBL] [Abstract][Full Text] [Related]
2. The role of polymorphisms in glutathione-related genes in asbestos-related diseases.
Franko A; Goricar K; Dodic Fikfak M; Kovac V; Dolzan V
Radiol Oncol; 2021 Jan; 55(2):179-186. PubMed ID: 33544514
[TBL] [Abstract][Full Text] [Related]
3. A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients.
Cui L; Li Y; Ma G; Wang Y; Cai Y; Liu S; Chen Y; Li J; Xie Y; Liu G; Zhao B; Li K
PLoS One; 2014; 9(2):e89019. PubMed ID: 24586483
[TBL] [Abstract][Full Text] [Related]
4. The association of genetic factors with serum calretinin levels in asbestos-related diseases.
Zupanc C; Franko A; Strbac D; Kovac V; Dolzan V; Goricar K
Radiol Oncol; 2023 Dec; 57(4):473-486. PubMed ID: 38038422
[TBL] [Abstract][Full Text] [Related]
5. Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
Lee MJ; Kuehne N; Hueniken K; Liang S; Rai S; Sorotsky H; Herman M; Shepshelovich D; Bruce J; Liang M; Patel D; Cheng D; Chen Z; Eng L; Brown MC; Cho J; Leighl NB; de Perrot M; Reisman D; Xu W; Bradbury PA; Liu G
Mol Carcinog; 2019 Nov; 58(11):1960-1973. PubMed ID: 31355511
[TBL] [Abstract][Full Text] [Related]
6. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
[TBL] [Abstract][Full Text] [Related]
7. [Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis].
Polverosi R; Vigo M; Citton O
Radiol Med; 2000 Nov; 100(5):326-31. PubMed ID: 11213409
[TBL] [Abstract][Full Text] [Related]
8. The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma.
Levpuscek K; Goricar K; Kovac V; Dolzan V; Franko A
Radiol Oncol; 2019 Mar; 53(2):206-212. PubMed ID: 30893058
[TBL] [Abstract][Full Text] [Related]
9. Chemokines involved in the early inflammatory response and in pro-tumoral activity in asbestos-exposed workers from an Italian coastal area with territorial clusters of pleural malignant mesothelioma.
Comar M; Zanotta N; Zanconati F; Cortale M; Bonotti A; Cristaudo A; Bovenzi M
Lung Cancer; 2016 Apr; 94():61-7. PubMed ID: 26973208
[TBL] [Abstract][Full Text] [Related]
10. Pleural plaques and the risk of pleural mesothelioma.
Pairon JC; Laurent F; Rinaldo M; Clin B; Andujar P; Ameille J; Brochard P; Chammings S; Ferretti G; Galateau-Sallé F; Gislard A; Letourneux M; Luc A; Schorlé E; Paris C
J Natl Cancer Inst; 2013 Feb; 105(4):293-301. PubMed ID: 23355760
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma.
Landi S; Gemignani F; Neri M; Barale R; Bonassi S; Bottari F; Canessa PA; Canzian F; Ceppi M; Filiberti R; Ivaldi GP; Mencoboni M; Scaruffi P; Tonini GP; Mutti L; Puntoni R
Int J Cancer; 2007 Jun; 120(12):2739-43. PubMed ID: 17290392
[TBL] [Abstract][Full Text] [Related]
12. Pleural plaques as risk indicators for malignant pleural mesothelioma: a necropsy-based study.
Bianchi C; Brollo A; Ramani L; Zuch C
Am J Ind Med; 1997 Nov; 32(5):445-9. PubMed ID: 9327067
[TBL] [Abstract][Full Text] [Related]
13. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.
Cvitanović S; Znaor L; Konsa T; Ivancević Z; Perić I; Erceg M; Vujović M; Vuković J; Beg-Zec Z
Croat Med J; 2003 Oct; 44(5):618-25. PubMed ID: 14515425
[TBL] [Abstract][Full Text] [Related]
14. Genes involved in innate immunity associated with asbestos-related fibrotic changes.
Kukkonen MK; Vehmas T; Piirilä P; Hirvonen A
Occup Environ Med; 2014 Jan; 71(1):48-54. PubMed ID: 24142982
[TBL] [Abstract][Full Text] [Related]
15. Impact of miR-SNP rs2910164 on miR-146a expression in osteoarthritic chondrocytes.
Papathanasiou I; Mourmoura E; Balis C; Tsezou A
Adv Med Sci; 2020 Mar; 65(1):78-85. PubMed ID: 31918067
[TBL] [Abstract][Full Text] [Related]
16. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
Tunesi S; Ferrante D; Mirabelli D; Andorno S; Betti M; Fiorito G; Guarrera S; Casalone E; Neri M; Ugolini D; Bonassi S; Matullo G; Dianzani I; Magnani C
Carcinogenesis; 2015 Oct; 36(10):1129-35. PubMed ID: 26139392
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases.
Franko A; Goricar K; Kovac V; Dodic-Fikfak M; Dolzan V
J Med Biochem; 2020 Jan; 39(1):91-99. PubMed ID: 32549782
[TBL] [Abstract][Full Text] [Related]
18. The Association Between the FTO rs9939609 Variant and Malignant Pleural Mesothelioma Risk: A Case-Control Study.
Khella MS; Salem AM; Abdel-Rahman O; Saad AS
Genet Test Mol Biomarkers; 2018 Feb; 22(2):79-84. PubMed ID: 29260910
[TBL] [Abstract][Full Text] [Related]
19. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.
Dragon J; Thompson J; MacPherson M; Shukla A
J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056
[TBL] [Abstract][Full Text] [Related]
20. miRNA polymorphisms (miR‑146a, miR‑149, miR‑196a2 and miR‑499) are associated with the risk of coronary artery disease.
Sung JH; Kim SH; Yang WI; Kim WJ; Moon JY; Kim IJ; Cha DH; Cho SY; Kim JO; Kim KA; Kim OJ; Lim SW; Kim NK
Mol Med Rep; 2016 Sep; 14(3):2328-42. PubMed ID: 27430349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
